Medindia
Medindia LOGIN REGISTER
Advertisement

Rigel Announces First Quarter 2010 Financial Results

Tuesday, May 4, 2010 General News
Advertisement

STATEMENTS OF OPERATIONS

(in thousands, except per share amounts)

Three Months Ended March 31,

2010

2009

(unaudited)

Revenues:

Contract revenues

$           3,261

$                  -

Operating expenses:

Research and development (see Note A)

17,425

24,538

General and administrative (see Note A)

8,186

4,603

Restructuring charges (see Note A)

-

1,141

    Total operating expenses

25,611

30,282

Loss from operations

(22,350)

(30,282)

Interest income, net

17

294

Loss before income taxes

(22,333)

(29,988)

Income tax benefit

-

66

Net loss

$       (22,333)

$         (29,922)

Net loss per share, basic and diluted

$           (0.43)

$             (0.82)

Weighted average shares used in computing

   net loss per share, basic and diluted

51,964

36,699

Note A

Stock-based compensation expense included in:

Research and development

$           3,083

$            1,425

General and administrative

2,084

719

Restructuring charges

-

122

$           5,167

$            2,266

SUMMARY BALANCE SHEET DATA

(in thousands)

March 31,

December 31,

2010

2009(1)

(unaudited)

Cash, cash equivalents and available

      for sale securities

$       109,549

$        133,318

Total assets

217,145

140,744

Stockholders' equity

92,785

109,867

(1)

Derived from audited financial statements

Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close